Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study

Abstract Background This study aimed to compare the efficacy and safety of baricitinib in patients with rheumatoid arthritis (RA) receiving different doses based on renal function. Methods We conducted a retrospective study within the JAK Study Group, involving 23 facilities in Fukuoka Prefecture, e...

Полное описание

Библиографические подробности

Главные авторы:	Akira Maeyama, Masakazu Kondo, Hiroshi Harada, Eisuke Shono, Ryuji Nagamine, Tomomi Tsuru, Yasushi Inoue, Munetoshi Nakashima, Yutaro Yamasaki, Hiroaki Niiro, Yasuharu Nakashima, Takuaki Yamamoto
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2024-12-01
Серии:	BMC Rheumatology
Предметы:	Baricitinib JAK inhibitor Japan Propensity score matching Rheumatoid arthritis
Online-ссылка:	https://doi.org/10.1186/s41927-024-00446-y
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!